Stable Complexes Involving Acetylcholinesterase and Amyloid-β Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer’s Fibrils
暂无分享,去创建一个
B. P. Doctor | N. Inestrosa | C. Opazo | M. K. Gentry | Nibaldo C. Inestrosa | F. J. Muñoz | Alejandra Alvarez | Rodrigo Alarcón | Carlos Opazo | Eliseo O. Campos | Francisco José Muñoz | Frances H. Calderón | Federico Dajas | Mary K. Gentry | Bhupendra P. Doctor | Fernando G. De Mello | A. Álvarez | R. Alarcón | F. Dajas | E. O. Campos | F. Calderón | F. D. de Mello
[1] C. Geula,et al. Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles , 1987, Annals of neurology.
[2] B. P. Doctor,et al. A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme. , 1997, Biochemical and biophysical research communications.
[3] Claudia Linker,et al. Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme , 1996, Neuron.
[4] E. Mufson,et al. Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain , 1992, Brain Research.
[5] F. Grosveld,et al. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. , 1998, Science.
[6] K. Courtney,et al. A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.
[7] D. Selkoe,et al. Alzheimer's Disease--Genotypes, Phenotype, and Treatments , 1997, Science.
[8] F. Vallette,et al. Molecular and cellular biology of cholinesterases , 1993, Progress in Neurobiology.
[9] N. Inestrosa,et al. Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides , 1995, Neuroscience Letters.
[10] Y. Mimori,et al. Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor , 1997, Behavioural Brain Research.
[11] M Nirenberg,et al. Synapse turnover: the formation and termination of transient synapses. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[12] N. Inestrosa,et al. Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments. , 1996, Molecular psychiatry.
[13] M. Mesulam,et al. Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Karnovsky,et al. A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES , 1964, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[15] C. Geula,et al. Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease , 1990, Neuroscience Letters.
[16] S. Snyder,et al. Gamma-aminobutyric acid (GABA) receptor binding in mammalian retina , 1976, Brain Research.
[17] Y. Ashani,et al. Characterization of Monoclonal Antibodies that Inhibit the Catalytic Activity of Acetylcholinesterases , 1995, Journal of neurochemistry.
[18] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[19] R. Silveira,et al. Fasciculin, a powerful anticholinesterase polypeptide from Dendroaspis angusticeps venom , 1983, Neurochemistry International.
[20] A. W. Peck,et al. Hydrolysis of suxamethonium by different types of plasma , 1969, British journal of pharmacology.
[21] Peter Davies,et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans , 1992, Neurobiology of Aging.
[22] L. Greene,et al. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Lansbury,et al. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[24] L. Thal,et al. Properties of dopamine agonist and antagonist binding sites in mammalian retina , 1980, Brain Research.
[25] U. Bachrach,et al. ORNITHINE AND GLUTAMIC ACID DECARBOXYLASE ACTIVITIES IN THE DEVELOPING CHICK RETINA , 1976, Journal of neurochemistry.
[26] C. Geula,et al. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue , 1991, Brain Research.
[27] C. Geula,et al. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease , 1989, Brain Research.
[28] G. Getz,et al. Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal Cultures , 1997, Journal of neurochemistry.
[29] C. Soto,et al. Structural Determinants of the Alzheimer's Amyloid β‐Peptide , 1994 .
[30] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] M. Pras,et al. Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L , 1995, The Journal of Biological Chemistry.
[32] C. Wernstedt,et al. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain , 1995, Neuron.
[33] N. Inestrosa,et al. Cellular localization of the molecular forms of acetylcholinesterase in rat pheochromocytoma PC12 cells treated with nerve growth factor , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[34] N. Inestrosa,et al. Distribution and anchoring of molecular forms of acetylcholinesterase. , 1989, Trends in pharmacological sciences.
[35] B. Yankner,et al. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Nirenberg,et al. Localization of Acetylcholine Receptors during Synaptogenesis in Retina (a-bungarotoxin/neuron Development/cultured Neurons) , 2022 .
[37] D. Selkoe,et al. Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease , 1988, Cell.
[38] D. Nochlin,et al. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.
[39] E. Rojas,et al. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[40] P. Layer. Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease , 1996, Neurochemistry International.
[41] M. Nirenberg,et al. Muscarinic acetylcholine receptors of the developing retina. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[42] P. Taylor,et al. The cholinesterases. , 1991, The Journal of biological chemistry.
[43] M. Mattson,et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[45] D. Kukuruga,et al. Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[46] P. May,et al. Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity , 1996 .
[47] J. Hofrichter,et al. Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism. , 1985, Journal of molecular biology.
[48] N. Inestrosa,et al. Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterases in other tissues. , 1987, The Journal of biological chemistry.
[49] B. Solomon,et al. Disaggregation of Alzheimer β-amyloid by site-directed mAb , 1997 .
[50] N. Inestrosa,et al. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. , 1997, Journal of molecular biology.
[51] P. Cras,et al. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Hofrichter,et al. Kinetics of sickle hemoglobin polymerization. I. Studies using temperature-jump and laser photolysis techniques. , 1985, Journal of molecular biology.
[53] Bruce A. Yankner,et al. Methodological variables in the assessment of beta amyloid neurotoxicity , 1992, Neurobiology of Aging.
[54] R. Silveira,et al. Rat striatal acetylcholinesterase inhibition by Fasciculin (a polypeptide from green mamba snake venom) , 1987, Neuroscience Letters.
[55] C. Geula,et al. Protease Inhibitors and Indolamines Selectively Inhibit Cholinesterases in the Histopathologic Structures of Alzheimer's Disease a , 1993, Annals of the New York Academy of Sciences.
[56] R. Kalaria,et al. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease , 1992, Neuroscience.
[57] E. Otomo,et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.
[58] K. Iqbal,et al. Alzheimer's disease : biology, diagnosis, and therapeutics , 1996 .
[59] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[60] E. Karlsson,et al. Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps. , 1984, Journal de physiologie.
[61] D. Selkoe,et al. Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.
[62] J. Sheffield,et al. Electron microscopic analysis of aggregation of embryonic cells: the structure and differentiation of aggregates of neural retina cells. , 1970, Developmental biology.
[63] R. Wetzel,et al. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[64] C. Geula,et al. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia , 1994, Annals of neurology.
[65] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.
[66] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[67] P. Taylor,et al. Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. , 1991, Molecular pharmacology.
[68] Carl W. Cotman,et al. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[69] N. Inestrosa,et al. Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro , 1998, Molecular Psychiatry.
[70] B. Yankner,et al. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.
[71] L. Villa-komaroff,et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. , 1989, Science.
[72] C. Glabe,et al. Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation. , 1994, The Journal of biological chemistry.
[73] J. Pettegrew,et al. Two simple methods for quantifying low-affinity dye-substrate binding. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[74] Steven A. Johnson,et al. Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress , 1995, Experimental Neurology.
[75] B. Yankner. Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.
[76] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[77] S. Nakano,et al. Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization. , 1990, Journal of neural transmission. Supplementum.
[78] K. Gulya,et al. The cholinergic system in Alzheimer's disease , 1997, Progress in Neurobiology.
[79] M. Nirenberg,et al. Synapse and acetylcholine receptor synthesis by neurons dissociated from retina. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[80] H. Schägger,et al. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.
[81] M A Markwell,et al. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. , 1982, Analytical biochemistry.
[82] D. Mann,et al. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome , 1989, Journal of the Neurological Sciences.
[83] Shen Zx. Acetylcholinesterase provides deeper insights into Alzheimer's disease , 1994 .
[84] K. Higuchi,et al. Kinetic analysis of amyloid fibril polymerization in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[85] Claudia H. Kawas,et al. The epidemiology of dementia and Alzheimer disease. , 1994 .
[86] F. G. Mello,et al. Adenosine‐Elicited Accumulation of Adenosine 3′, 5′‐Cyclic Monophosphate in the Chick Embryo Retina , 1982 .
[87] W. Surewicz,et al. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. , 1997, Chemical research in toxicology.